Elekta: Invitation to telephone conference

Elekta: Invitation to telephone conference

Elekta's interim report for the third quarter 2010/11 will be published
on Tuesday, March 8 at around 07.30 CET. A telephone conference will be
held the same day at 10.00-11.00 CET.

During the telephone conference, Tomas Puusepp, President and CEO, and
Håkan Bergström, CFO, will present the nine months results and answer
questions.

To take part in the conference call, please dial in about five minutes
in advance.

Call-in numbers for telephone conference March 8 at 10.00-11.00 CET

UK:                            +44 (0)207 162 0077
US:                            +1 334 323 6201
Norway:                     +47 2156 31 20
France:                      +33 (0)1 7099 3208
Germany:                   +49 (0)695 8999 0507
Sweden:                     +46 (0)8 5052 0110

The teleconference will also be broadcasted over the Internet. Please
visit www.elekta.com - Investor Events, or use the direct link:
http://webeventservices.stream57.com/20110308elekta (http://webeventserv
ices.stream57.com/20110308elekta)

The telephone conference will be available afterwards on instant replay
for seven days. Please dial UK: +44 (0)207 031 40 64, Sweden: +46
(0)8 505 203 33, US: +1 954 334 03 42 and use access code 889226.

******

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 25 437, +46 70 778 6010, e-mail:
stina.thorman@elekta.com   

About Elekta

Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated state of the art tools and treatment planning
systems for radiation therapy and radiosurgery, as well as workflow
enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients
receive diagnosis, treatment or follow-up with the help of a solution
from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is listed
on the Nordic Exchange under the ticker EKTAb. For more information
about Elekta, please visit www.elekta.com.